According to Musk’s tweet on August 4, 2024, Neuralink has implanted a brain chip in a second trial patient. The article states that Neuralink is developing brain-computer interfaces to help treat neurological conditions. The U.S. Food and Drug Administration has approved the company to test its device in humans.
Editor’s Note: Neuralink’s human trials raise significant ethical and medical concerns that could have dire consequences for participants. The risks associated with brain surgery, such as infection or severe neurological damage, are compounded by the uncertainty surrounding the long-term functionality of the implanted devices. If Neuralink faced financial or operational failures, patients could have non-functional implants that are difficult or impossible to remove.
Furthermore, the potential for misuse of the technology, including privacy violations or manipulation of thoughts, poses profound ethical dilemmas. The hype surrounding Musk’s vision may lead participants to underestimate these risks, making informed consent a critical issue that requires careful consideration and transparent communication from the company. [Also read Neuralink Claims First Successful Implantation of Wireless Brain Chips In Humans, The transhumanist dream: For humans to become computers].
Read Original Article
Read Online
Click the button below if you wish to read the article on the website where it was originally published.
Read Offline
Click the button below if you wish to read the article offline.